Sylvie Louise Grégoire is a Canadian businessperson who founded EIP Pharma, Inc. and who has been at the helm of 6 different companies. Presently, she is Executive Chairman at this company and Chairman for Corvidia Therapeutics, Inc.
She is also on the board of PerkinElmer, Inc. (United States), Novo Nordisk An and Shire Orphan Therapies GmbH.
In her past career Dr. Grégoire occupied the position of Chairman of Metriopharm AG, Executive Vice President-Business Development of Biogen, Inc. and Executive Vice President-Technical Operations at Biogen MA, Inc. (a subsidiary of Biogen, Inc.), Executive Chairman for IDM Pharma, Inc., President, CEO & Executive Director at GlycoFi, Inc., President for Shire Human Genetic Therapies, Inc. and President-Human Genetic Therapies Division at Shire Plc.
She received an undergraduate degree from Université Laval and a doctorate from State University of New York at Buffalo.